PHF2 anticorps (AA 70-82)
-
- Antigène Voir toutes PHF2 Anticorps
- PHF2 (PHD Finger Protein 2 (PHF2))
-
Épitope
- AA 70-82
-
Reactivité
- Eucaryotes
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp PHF2 est non-conjugé
-
Application
- Western Blotting (WB)
- Purification
- Affinity chromatography purified
- Immunogène
- PHF2 antibody was raised in rabbit using AA 70-82 [KHGPGPTPDVKRVC] of the 120 kDa PHF protein as the immunogen.
- Isotype
- IgG
- Top Product
- Discover our top product PHF2 Anticorps primaire
-
-
- Indications d'application
-
WB: 1:500-1:1,000
Optimal conditions should be determined by the investigator. - Restrictions
- For Research Use only
-
- Concentration
- Lot specific
- Buffer
- Affinity purified IgG supplied in PBS with 0.02 % NaN3.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
-
- Antigène
- PHF2 (PHD Finger Protein 2 (PHF2))
- Autre désignation
- PHF2 (PHF2 Produits)
- Synonymes
- anticorps CENP-35, anticorps GRC5, anticorps JHDM1E, anticorps im:4200679, anticorps phf8, anticorps wu:fa14c10, anticorps PHD finger protein 2, anticorps PHF2, anticorps Phf2, anticorps phf2
- Sujet
- Plant homeodomain (PHD) finger protein 2 (PHF2) is a putative transcription factor. PHF2 contains a zinc finger-like PHD domain that is distinct from other classes of zinc finger motifs and is often found in proteins that influence chromatin structure. It also contains a Jumonji C (JmjC) domain, which may play a role in histone demethylation. The PHF2 gene is ubiquitously expressed in adult mouse tissues, however, the majority of PHF2 expression in the mouse embryo occurs in the neural tube and root ganglia. PHF2 mutations have been associated with both early- and late-onset breast carcinoma.
-